Sanofi and Magorium: Paving new roads to achieve growth in regional markets
THE PARTNERSHIP
Sanofi's new S$800 million state-of-the-art manufacturing facility, Modulus, in Singapore serves as a blueprint for sustainable biopharmaceutical production. This modular concept facility not only represents a significant investment into Singapore’s vibrant biopharma industry but also embodies a strategic commitment to environmental sustainability. By integrating eco-friendly features into its core design and construction, Sanofi is pioneering new standards for a more sustainable future in the biopharmaceutical industry.
The next-generation facility has been designed with the lowest possible carbon footprint with optimised waste management and renewable energy, demonstrating how large-scale industrial projects can successfully embed green initiatives from the outset.
A notable feature of the 58,000 square metre Modulus facility is the innovative use of recycled plastics including discarded insulin pens for paving its roads. That amounts to about 1.5km worth of roads — about the length of 15 soccer fields.
This was made possible through a strategic partnership with local deep-tech enterprise, Magorium, showcasing how MNCs can partner with innovative enterprises in Singapore to achieve specific sustainability goals.
Magorium's proprietary technology transforms unsorted plastic waste into NEWBitumen, a sustainable substitute for crude-derived bitumen.
The two companies also partnered with the National University Hospital in Singapore to collect medical waste such as Sanofi’s insulin pens recycling initiative. By transforming discarded medical waste into a valuable resource, the partnership proves that there is a viable and scalable solution for corporate waste management.
Approximately 800,000 Sanofi insulin pens are used annually, generating about 16.8 tonnes of plastic waste. Through the insulin pens recycling project, Sanofi has set an ambitious target to collect and recycle more than 70 per cent of their distributed pens.
Incidentally, collecting these used pens came with its own set of challenges such as a reliance on voluntary participation by consumers and the inability to properly predict volume of recoverable waste. The team subsequently learned that engaging customers at multiple touchpoints and working closely with pharmacists to monitor volume helped them overcome the respective challenges.
The technology has already been utilised elsewhere in Singapore, and Magorium is now exploring new pilot projects in the ASEAN region.